Do patients at high risk of Alzheimer's disease benefit from early treatment?
Metadata[+] Show full item record
Treating patients with early-stage Alzheimer's disease yields statistically significant, though perhaps not clinically significant, improvement in cognition and global function (strength of recommendation [SOR]: A, consistent evidence from multiple randomized controlled trials [RCTs]). In a few cases, it may delay loss of function and need for long-term care.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.